Melphalan
Showing 1 - 25 of 911
Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)
Active, not recruiting
- Multiple Myeloma
- Newly Diagnosed Patients
- Melphalan
- +2 more
-
Torino, ItalyDivision of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022
Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)
Not yet recruiting
- Multiple Myeloma
- Melphalan and Treosulfan
- Melphalan
- (no location specified)
Dec 5, 2022
Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)
Terminated
- Amyloidosis; Systemic
- Propylene Glycol-Free Melphalan Hydrochloride
-
Boston, MassachusettsBoston Medical Center
Jul 1, 2022
Multiple Myeloma Trial (RP followed by MPR)
Active, not recruiting
- Multiple Myeloma
- RP followed by MPR
- (no location specified)
Mar 24, 2022
Multiple Myeloma Trial in Beijing (melphalan HCl for injection)
Recruiting
- Multiple Myeloma
- melphalan hydrochloride for injection
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 26, 2022
Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)
Not yet recruiting
- Multiple Myeloma
- Evomela
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022
Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)
Completed
- Multiple Myeloma
- Melphalan
- Bendamustine
-
Berne, SwitzerlandDepartment for Medical Oncology University Hospital/Inselspital
Jul 29, 2021
Hematopoietic Stem Cell Transplantation Trial in Cincinnati (Melphalan)
Completed
- Hematopoietic Stem Cell Transplantation
- Melphalan
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 24, 2021
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Melanoma, Ocular Trial in Tampa, Durham (Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS))
Available
- Melanoma, Ocular
- Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS)
-
Tampa, Florida
- +1 more
Mar 23, 2022
Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)
Active, not recruiting
- Multiple Myeloma
- Amyloidosis
- Melphalan
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Cyclophosphamide
- +3 more
-
Torino, ItalyDivision of Hematology, Molinette Hospital
Apr 6, 2022
Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)
Recruiting
- Lymphoma
- +4 more
- Pharmacokinetics
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 12, 2022
Hematopoietic Stem Cell Transplantation Trial in Seoul (Melphalan)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Melphalan
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 23, 2021
Oral Mucositis in Patient's Undergoing Melphalan Conditioning
Withdrawn
- Mucositis
- +3 more
- Melphalan kinetic study
- +2 more
-
Indianapolis, Indiana
- +1 more
Jan 6, 2022
Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell
Completed
- Hematologic Malignancies
- +7 more
- Melphalan
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade
Active, not recruiting
- Multiple Myeloma
- velcade subcutaneous melphalan prednisone
- +2 more
-
Torino, ItalyA.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022
Retinoblastoma, Chemo Effect Trial in Guangzhou (Topotecan, Melphalan)
Recruiting
- Retinoblastoma
- Chemotherapy Effect
- Topotecan
- Melphalan
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Mar 12, 2021
Multiple Myeloma Trial in Torino (Melphalan, Prednisone, Lenalidomide, Cyclophosphamide, Prednisone, Lenalidomide, Lenalidomide,
Active, not recruiting
- Multiple Myeloma
- Melphalan, Prednisone, Lenalidomide
- +2 more
-
Torino, TO, ItalyDivision Of Hematology, A.O.U. Città della Salute e della Scienz
Mar 24, 2022
Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)
Recruiting
- Multiple Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Atlanta, Georgia
- +1 more
Feb 25, 2022
Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Auto Stem Cell Transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center @ Hackensack University Medical Cente
Aug 25, 2021
Renal Impairment, RRMM Trial in Czechia, Greece, Poland (Melphalan flufenamide (melflufen), Dexamethasone)
Terminated
- Renal Impairment
- RRMM
- Melphalan flufenamide (melflufen)
- Dexamethasone
-
Brno, Czechia
- +9 more
Feb 2, 2022
Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT
Not yet recruiting
- Multiple Myeloma
- Dara-VRd intensification, Dara-R maintenance
- +4 more
- (no location specified)
Apr 28, 2022
Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancies
- Busulfan 3.2 mg/kg/day
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 14, 2022